<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6D8A51BF-F00C-4A8C-8D0C-7AB82934E0BF"><gtr:id>6D8A51BF-F00C-4A8C-8D0C-7AB82934E0BF</gtr:id><gtr:firstName>Rosemary</gtr:firstName><gtr:surname>Boyton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/389AFFA9-1183-4D9E-A67C-FC3F7F7DC217"><gtr:id>389AFFA9-1183-4D9E-A67C-FC3F7F7DC217</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Altmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6CAA9789-982F-4E04-98E0-A8403E18070E"><gtr:id>6CAA9789-982F-4E04-98E0-A8403E18070E</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>W</gtr:otherNames><gtr:surname>Kwok</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15106"><gtr:id>EB99ADD0-CB99-4F4F-9FF0-49E35A5195BB</gtr:id><gtr:title>Zika: CD4 T cell immune correlates of Zika virus exposure</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15106</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Current knowledge of T cell immunity to Zika virus is minimal. For a disease of such diverse
outcomes, from asymptomatic exposure to Guilain-Barre syndrome or neonatal
microcpephaly, there is a pressing need to characterise immunity to identify the difference
between protective and pathogenic T cell responses. In West Nile virus (WNV) infection, for
example, neuropathogenic complications are themselves attributed to effects of T cells. We
aim to supply the Zika research community with the first detailed dataset of CD4 T cell
immunity to Zika virus, establishing the immune correlates of different disease outcomes
after exposure. Our expertise and track-record in this regard is based in &amp;gt;12 years funding to
the Altmann/Boyton and Kwok/James teams within the consortia of the NIH Epitope
Discovery Program (IEDB). This has been a programme of high-throughput analysis to
achieve rapid characterisation of immunity in response to emerging pathogens. As such, the
teams are ready to go with precisely the toolkit required for the proposed study. Kwok/James
have led the way in characterisation of protective/pathogenic flavivirus immune correlates,
generating tetramers for multiple HLA alleles. The London and Seattle labs will here team
with Silva?s lab in Sao Paulo. Patients will be characterised, covering phenotypes from mild to
severe, and CD4 T cell immunity analysed against the protein antigens ENV, NS5, NS3, and
NS1. This will include qualitative and quantitative aspects, by ELIspot and HLA/Zika tetramer
flow cytometry, allowing immune correlates of disease outcome to be annotated. The
reagent set will subsequently be invaluable for monitoring of Zika vaccine trials.</gtr:technicalSummary><gtr:fund><gtr:end>2017-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-31</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>31061</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NIH-NIAID. Within-scope funding extension: Comprehensive CD4 T cell epitope discovery from Zika virus.</gtr:description><gtr:id>003EF7E8-7795-4E37-B3BC-0E53F53C7C1E</gtr:id><gtr:impact>About to write manuscripts</gtr:impact><gtr:outcomeId>58c967fa132522.14801932-1</gtr:outcomeId><gtr:partnerContribution>A large number of Zika CD4 epitopes have been characterised</gtr:partnerContribution><gtr:piContribution>Collaborative funding following on from this MRC-Newton award; studies with David Koelle (U.WASH), Bill Kwok (Benaroya), Roque Almeida (U. Sergipe), Tatjana Keesen (U. Paraiba) to further extend our analysis of Zika CD4 T cell immunology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Imperial College Trust</gtr:department><gtr:description>Guillain Barre syndrome antibodies during Zika and Cikungunya vaccine trials</gtr:description><gtr:id>3153602E-4278-48CC-981D-6D00080FEBBA</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58c9b1a457af15.46098108-1</gtr:outcomeId><gtr:partnerContribution>Application of glycolipid arrays to define GBS antobodies</gtr:partnerContribution><gtr:piContribution>Characterisation of GBS sera</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Museum October Lates</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>95EF0000-1601-4093-8EB8-EA04F320FE4C</gtr:id><gtr:impact>As part of the 'October Lates' evening events at the Science Museum I gave a series of talks on the Zika crisis</gtr:impact><gtr:outcomeId>58c9b4a4428766.12161431</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>NIH-NIAID. Within-scope funding extension: Comprehensive CD4 T cell epitope discovery from Zika virus.</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:fundingOrg><gtr:id>9180B1BB-9C2A-436B-B668-F50D6DDF60BF</gtr:id><gtr:outcomeId>58c9b3c8218cc9.24787527</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>271764</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Guillain Barre syndrome antibodies during Zika and Cikungunya vaccine trials</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:id>4D22465D-EFD0-47EC-9E9B-A9F0A6AFEDCF</gtr:id><gtr:outcomeId>58c9b33c561ee3.73706133</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6D88C9C0-12EC-4886-9556-DD70F3915579</gtr:id><gtr:title>Guillain-Barr&amp;eacute; syndrome and arboviral infection in Brazil.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54bb630169fdd115d2e1f8eb20771b4d"><gtr:id>54bb630169fdd115d2e1f8eb20771b4d</gtr:id><gtr:otherNames>Keesen TSL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5a578bafb635f7.51214794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3E1BD25-DD18-4038-BF39-59F7F467E3E6</gtr:id><gtr:title>T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708d3bf2e2b92bbacb6971e20028f78a"><gtr:id>708d3bf2e2b92bbacb6971e20028f78a</gtr:id><gtr:otherNames>Reynolds CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a6ef2cfabf9e4.42990286</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15106</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>